Clinical Trials Logo

Filter by:
NCT ID: NCT00833066 Completed - Clinical trials for Seasonal Allergic Rhinoconjunctivitis

Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis

Start date: February 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether the oral administration of grass pollen peptides is safe and effective in the treatment of allergic rhinitis.

NCT ID: NCT00833001 Completed - Cystocele Clinical Trials

Clinical Performance of the GYNECARE PROLIFT + M* Pelvic Floor Repair System as a Device for Pelvic Organ Prolapse

Start date: April 2008
Phase: Phase 2/Phase 3
Study type: Observational

The purpose of this study is to evaluate the clinical performance of the PROLIFT system with a new lighter-weight mesh in repair of vaginal prolapse.

NCT ID: NCT00831909 Completed - NSCLC Clinical Trials

Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN

EPICLIN
Start date: January 2009
Phase: N/A
Study type: Observational

To provide accurate and reliable information regarding NSCLC clinical management across European countries in order to detect unmet medical needs of this disease in terms of: patient and hospital characteristics; diagnostic and treatment approaches: initial and subsequent, follow-up patterns in clinical management; outcomes: symptoms, death, functionality, quality of life; use of resources and burden on patients and health care systems.

NCT ID: NCT00831714 Completed - Clinical trials for Venous Thromboembolism

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

XAMOS
Start date: February 2009
Phase: N/A
Study type: Observational

The main goal is to provide additional information to the risk-benefit assessment of the drug.

NCT ID: NCT00831636 Completed - Ovarian Cancer Clinical Trials

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Start date: April 2008
Phase: Phase 1/Phase 2
Study type: Interventional

This is non randomised, open label, dose finding, efficacy and safety study, enrolling patients with advanced (stage III and IV) ovarian cancer It will be conducted in two successive phases. Phase II has a two-step design

NCT ID: NCT00830778 Completed - Tumors Clinical Trials

Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The incidence of complications after pancreaticoduodenectomy (PD) is around 50 %. The postoperative course after PD is strongly dependent of the occurrence of pancreatic fistula (POPF), which determines postoperative mortality, length of hospital stay and costs. The incidence of POPF after PD is dependent of its definition, and is reported in up to 20% of patients. There is disagreement on whether to perform a pancreaticojejunostomy (PJ) or a pancreaticogastrostomy (PG) after PD. The aim of the current randomized controlled trial is to study whether PG significantly reduces the rate of POPF following PD for pancreatic or peri-ampullary tumours. Secondary endpoints are the reduction of overall postoperative complication rate and their severity.

NCT ID: NCT00829374 Completed - Alzheimer's Disease Clinical Trials

Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

CONCERT
Start date: March 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if Dimebon is safe and effective in patients with mild to moderate Alzheimer's disease on Donepezil.

NCT ID: NCT00828672 Completed - Clinical trials for Locally Advanced Rectal Cancer

Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer

AXEBEAM
Start date: June 2009
Phase: Phase 2
Study type: Interventional

Phase II clinical trial, open-label, randomized, two arms, multicentre (possibly multinational). Academic, investigator initiated. To assess the activity of bevacizumab (AvastinTM) in combination with capecitabine (XelodaTM) and radiation therapy with or without oxaliplatin (EloxatinTM) in the pre-operative treatment of locally advanced rectal cancer, followed by TME (total mesorectal excision).

NCT ID: NCT00827944 Completed - Hernia, Inguinal Clinical Trials

Parietex Progrip Study

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The objective of the study is to evaluate pain and disabling complications inducing social consequences in primary inguinal hernia ProGrip mesh repair compared to Lichtenstein repair with lightweight polypropylene mesh.

NCT ID: NCT00827606 Completed - Clinical trials for Familial Hypercholesterolemia

Atorvastatin Three Year Pediatric Study

Start date: March 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to characterize three year descriptive growth and development (ie, height, weight, body mass index, Tanner Stage) and efficacy of cholesterol reduction in pediatric subjects with Heterozygous Familial Hypercholesterolemia receiving atorvastatin treatment.